An apolipoprotein E3 (ApoE3) assay is an ideal clinical assay for identifying problematic remnant lipoproteins like VLDL.

“if you could add one clinical assay to the Arsenal of lipid ologists it would be an a possi three assay is that still true”

“so when you are presuming we're both insulin sensitive our VLDL really don't pose much of an Astra genic risk because they stick around for such a short period of time so we don't have many of them they don't stick around long our a possi 3 is quite down regulated but if a possi 3 is up regulated and it's hard to measure this although Sam tameka's is working on an assay to do so you have VLDL now start to act like LDL they stick around long enough they have a high enough residence time in the plasma that they become atherogenic”